First, the TLDR: The first study mentioned was not a study of the effectiveness of hydroxychloroquine in treating covid patients, and did not mention hydroxychloroquine in its conclusions.
The long version: the study looked at a thousand patients who were already in treatment when they caught covid. 103 of them had lupus (SLE), 524 had rheumatoid arthritis (RA), and 486 had spondyloarthritis (SLA). Prior to catching covid 193 of these patients were being treated with hydroxychloroquine.
So hydroxychloroquine (HCQ) was mentioned in this study only because some patients were already on it when they got covid.
There is no mention of the use of HCQ in the study's conclusion: "Our data suggest that patients with SLE and RA do not show a different COVID-19 outcome, while patients with SPA have a more favourable disease course compared with those with SLE. Risk of hospitalisation with ventilation or death was associated with age >65 years, hypertension and PDN (prednisone) use in patients with SLE." https://lupus.bmj.com/content/lupusscimed/10/2/e000945.full.pdf
Perhaps the other studies were equally misrepresented by Bullshityouharder's sources.
Here is the disclaimer at the bottom of the linked page folks: "We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols." Go ahead and read it yourself. It's good advice.
First, the TLDR: The first study mentioned was not a study of the effectiveness of hydroxychloroquine in treating covid patients, and did not mention hydroxychloroquine in its conclusions.
The long version: the study looked at a thousand patients who were already in treatment when they caught covid. 103 of them had lupus (SLE), 524 had rheumatoid arthritis (RA), and 486 had spondyloarthritis (SLA). Prior to catching covid 193 of these patients were being treated with hydroxychloroquine.
So hydroxychloroquine (HCQ) was mentioned in this study only because some patients were already on it when they got covid.
There is no mention of the use of HCQ in the study's conclusion: "Our data suggest that patients with SLE and RA do not show a different COVID-19 outcome, while patients with SPA have a more favourable disease course compared with those with SLE. Risk of hospitalisation with ventilation or death was associated with age >65 years, hypertension and PDN (prednisone) use in patients with SLE." https://lupus.bmj.com/content/lupusscimed/10/2/e000945.full.pdf
Perhaps the other studies were equally misrepresented by Bullshityouharder's sources.
Lol you can't read.